Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation (PAF)
Evaluating the Efficacy of Circumferential Pulmonary Vein Ablation (CPVA) Versus Segmental Pulmonary Vein Isolation (SPVI) in Paroxysmal Atrial Fibrillation
Sponsor: University of California, San Diego
This NA trial investigates Atrial Arrhythmia and Paroxysmal Atrial Fibrillation and is currently completed. University of California, San Diego leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2021 — Jun 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
-
Nov 2018 — Jan 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .